Page last updated: 2024-08-23

lovastatin and Nephrotic Syndrome

lovastatin has been researched along with Nephrotic Syndrome in 36 studies

Research

Studies (36)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (11.11)	18.7374
1990's	28 (77.78)	18.2507
2000's	2 (5.56)	29.6817
2010's	2 (5.56)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fan, J; Jiang, L; Kong, X; Li, Z; Wu, T; Yuan, H	1
Chen, L; Liang, SF; Shu, GY; Wang, WM; Wei, LX; Wu, JB; Zhang, XH	1
Aguilar, P; Muñoz Díaz, AB	1
Azrolan, N; Bostom, A; Brown, CD; Friedman, EA; Roberts, KG; Thomas, L; Zhao, ZH	1
Tareeva, IE	1
Bahner, U; Heidland, A; Paczek, L; Schaefer, L; Schaefer, RM; Teschner, M	1
Berkley, V; Brouhard, BH; Cressman, M; Inman, S; Irwin, K; Satoh, S; Stowe, N; Takamori, H	1
Correia, AM; Miguel, MJ; Nogueira, AC; Pinto, JR; Prata, MM; Rodrigues, MC; Vicente, O	1
Gonzalo, A; Mampaso, F; Ortuño, J; Pascual, J	1
Böhler, J; Eckardt, HG; Schollmeyer, P; Wanner, C; Wieland, H	1
Harris, KP; Hattersley, JM; Moorhead, JF; Ramaswamy, C; Thomas, ME; Varghese, Z; Walls, J; Wheeler, DC; Williams, JD	1
Hendry, BM; Owen, JS; Scoble, JE; Streather, CP	1
Coleman, JE; Watson, AR	1
Poledne, R; Stejskalová, A; Stípek, S; Tĕmínová, J; Tesar, V; Zima, T	1
Biesenbach, G; Janko, O; Stuby, U; Zazgornik, J	1
Chacón, P; Piera, LL; Segarra, A; Vilardell, M	1
Byrne, MJ; Rayner, BL; van Zyl Smit, R	1
Breiteneder, S; Hörl, WH; Schmaldienst, S; Winkler, S	1
Kozlovskaia, NL; Miroshnichenko, NG; Popova, VV; Stavrovskaia, EV; Tareeva, IE	1
Drukker, A; Eddy, AA	1
Kolina, IB; Neverov, NI; Shilov, EM; Shvetsov, MIu; Stavrovskaia, EV; Zakharova, EV	1
Chan, PC; Cheng, IK; Robinson, JD; Tsang, MT; Yeung, HW; Yeung, WC	1
Boulton-Jones, JM; Grierson, D; Murray, L; Packard, CJ; Shepherd, J; Stewart, JP; Warwick, GL	1
Biesenbach, G; Zazgornik, J	1
Dardamanis, M; Elisaf, M; Pappas, M; Sferopoulos, G; Siamopoulos, KC	1
Erkelens, DW; Hené, RJ; Joles, JA; Koomans, HA; Rabelink, AJ	2
Moorhead, JF; Thomas, M	1
Ahmad, S	1
D'Amico, G; Gentile, MG	1
Camps, J; Joven, J; Masana, L; Simó, JM; Turner, PR; Vilella, E; Villabona, C	1
Harris, KP; Klahr, S; Purkerson, ML; Yates, J	1
Halstenson, CE; Kasiske, BL; Keane, WF; La Belle, P; Langendörfer, A; Velosa, JA	1
Joven, J; Masana, L; Turner, PR; Vilella, E	1
Bennett, WM; Golper, TA; Illingworth, DR; Morris, CD	1
Grundy, SM; Vega, GL	1

Reviews

2 review(s) available for lovastatin and Nephrotic Syndrome

Article	Year
Lipid-lowering agents for nephrotic syndrome. The Cochrane database of systematic reviews, 2013, Dec-10, Issue:12 Topics: Adult; Child; Fatty Acids, Monounsaturated; Fluvastatin; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Indoles; Lovastatin; Nephrotic Syndrome; Randomized Controlled Trials as Topic; Simvastatin	2013
[Kidney involvement in hereditary osteo-onychodysplasia]. Terapevticheskii arkhiv, 1997, Volume: 69, Issue:6 Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Diagnosis, Differential; Disease Progression; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Lovastatin; Nail-Patella Syndrome; Nephrotic Syndrome	1997

Trials

12 trial(s) available for lovastatin and Nephrotic Syndrome

Article	Year
Reduction of lipoprotein(a) following treatment with lovastatin in patients with unremitting nephrotic syndrome. American journal of kidney diseases : the official journal of the National Kidney Foundation, 1995, Volume: 26, Issue:1 Topics: Adult; Aged; Apolipoproteins A; Cholesterol; Cholesterol, LDL; Female; Humans; Lipoprotein(a); Lovastatin; Male; Middle Aged; Nephrotic Syndrome; Phenotype	1995
[New approaches to the treatment of nephritis]. Vestnik Rossiiskoi akademii meditsinskikh nauk, 1995, Issue:5 Topics: Animals; Cells, Cultured; Chronic Disease; Cyclophosphamide; Glomerulonephritis; Humans; Lovastatin; Lupus Nephritis; Mice; Nephritis; Nephrosclerosis; Nephrotic Syndrome; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Time Factors	1995
Long-term effect of lovastatin on lipoprotein profile in patients with primary nephrotic syndrome. Clinical nephrology, 1994, Volume: 41, Issue:5 Topics: Adult; Aged; Apolipoproteins B; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Female; Humans; Hyperlipidemias; Lipoproteins; Long-Term Care; Lovastatin; Male; Middle Aged; Nephrotic Syndrome; Patient Acceptance of Health Care; Prospective Studies; Proteinuria; Triglycerides	1994
Effects of simvastatin on lipoprotein (a) and lipoprotein composition in patients with nephrotic syndrome. Clinical nephrology, 1994, Volume: 41, Issue:3 Topics: Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Lipoprotein(a); Lipoproteins; Lovastatin; Male; Middle Aged; Nephrotic Syndrome; Simvastatin	1994
Simvastatin therapy for hypercholesterolemic patients with nephrotic syndrome or significant proteinuria. Kidney international, 1993, Volume: 44, Issue:5 Topics: Adolescent; Adult; Aged; Anticholesteremic Agents; Apolipoprotein B-100; Apolipoproteins B; Cholesterol, HDL; Cholesterol, LDL; Creatinine; Double-Blind Method; Female; Humans; Hypercholesterolemia; Inulin; Lovastatin; Male; Middle Aged; Nephrotic Syndrome; Placebos; Proteinuria; Simvastatin; Triglycerides	1993
Prospective case control study to determine the effect of lovastatin on serum testosterone and cortisol concentrations in hyperlipidemic nephrotic patients with chronic renal failure. Nephron, 1996, Volume: 73, Issue:2 Topics: Adult; Case-Control Studies; Follicle Stimulating Hormone; Humans; Hydrocortisone; Hyperlipidemias; Hypolipidemic Agents; Kidney Failure, Chronic; Lipids; Lovastatin; Luteinizing Hormone; Male; Middle Aged; Nephrotic Syndrome; Prospective Studies; Testosterone	1996
A prospective clinical trial comparing the treatment of idiopathic membranous nephropathy and nephrotic syndrome with simvastatin and diet, versus diet alone. Clinical nephrology, 1996, Volume: 46, Issue:4 Topics: Adult; Anticholesteremic Agents; Cholesterol; Cholesterol, Dietary; Combined Modality Therapy; Enzyme Inhibitors; Follow-Up Studies; Glomerulonephritis, Membranous; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Nephrotic Syndrome; Prospective Studies; Serum Albumin; Simvastatin; Time Factors	1996
Lovastatin in glomerulonephritis patients with hyperlipidaemia and heavy proteinuria. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1992, Volume: 7, Issue:2 Topics: Adult; Aged; Drug Tolerance; Female; Glomerulonephritis; Humans; Hyperlipidemias; Hypertriglyceridemia; Lovastatin; Male; Middle Aged; Nephrotic Syndrome; Proteinuria; Rhabdomyolysis	1992
Partial remission of nephrotic syndrome in patient on long-term simvastatin. Lancet (London, England), 1990, Apr-28, Volume: 335, Issue:8696 Topics: Aged; Anticholesteremic Agents; Clinical Trials as Topic; Female; Follow-Up Studies; Humans; Lovastatin; Male; Middle Aged; Nephrotic Syndrome; Remission Induction; Simvastatin	1990
Pharmacological and dietary treatment of lipid abnormalities in nephrotic patients. Kidney international. Supplement, 1991, Volume: 31 Topics: Cholestyramine Resin; Colestipol; Food, Formulated; Gemfibrozil; Humans; Hyperlipidemias; Lipids; Lovastatin; Nephrotic Syndrome; Probucol	1991
Lovastatin in the treatment of multifactorial hyperlipidemia associated with proteinuria. American journal of kidney diseases : the official journal of the National Kidney Foundation, 1989, Volume: 13, Issue:4 Topics: Adrenal Cortex Hormones; Adult; Cholesterol, Dietary; Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Female; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Nephrotic Syndrome; Proteinuria; Random Allocation	1989
Effects of simvastatin and cholestyramine on lipoprotein profile in hyperlipidaemia of nephrotic syndrome. Lancet (London, England), 1988, Dec-10, Volume: 2, Issue:8624 Topics: Adult; Aged; Anticholesteremic Agents; Apolipoproteins A; Apolipoproteins B; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Lipoproteins; Lovastatin; Male; Middle Aged; Nephrotic Syndrome; Random Allocation; Simvastatin	1988

Other Studies

22 other study(ies) available for lovastatin and Nephrotic Syndrome

Article	Year
Effects of lovastatin on hepatic expression of the low-density lipoprotein receptor in nephrotic rats. Genetics and molecular research : GMR, 2014, Feb-19, Volume: 13, Issue:1 Topics: Animals; Anticholesteremic Agents; Cholesterol, LDL; Disease Models, Animal; Hyperlipidemias; Liver; Lovastatin; Male; Nephrotic Syndrome; Rats; Rats, Sprague-Dawley; Receptors, LDL; Triglycerides	2014
[Idiopathic membranous nephropathy associated with anti-calcineurin toxicity. Prognosis and other immunosuppressive treatments]. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2004, Volume: 24 Suppl 3 Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcineurin Inhibitors; Calcium Channel Blockers; Creatinine; Cyclosporine; Drug Therapy, Combination; Glomerulonephritis, Membranous; Humans; Hypercholesterolemia; Hypertension; Hypolipidemic Agents; Immunosuppressive Agents; Kidney Diseases; Lisinopril; Lovastatin; Male; Nephrotic Syndrome; Prednisone; Recurrence; Verapamil	2004
Lovastatin ameliorates depressed intraglomerular proteolytic activities in experimental nephrotic syndrome. Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie, 1994, Volume: 194, Issue:6 Topics: Albuminuria; Animals; Doxorubicin; Endopeptidases; Glomerulosclerosis, Focal Segmental; Hyperlipidemias; Kidney Glomerulus; Lovastatin; Male; Nephrotic Syndrome; Proteinuria; Rats; Rats, Inbred Lew	1994
The combination of lovastatin and enalapril in a model of progressive renal disease. Pediatric nephrology (Berlin, Germany), 1994, Volume: 8, Issue:4 Topics: Animals; Disease Models, Animal; Disease Progression; Drug Therapy, Combination; Enalapril; Glomerular Filtration Rate; Lovastatin; Male; Nephrotic Syndrome; Rats; Rats, Sprague-Dawley	1994
Remission of nephrotic syndrome on lovastatin treatment. Nephron, 1994, Volume: 66, Issue:2 Topics: Humans; Lovastatin; Male; Middle Aged; Nephrotic Syndrome	1994
Incubation of porcine high-density lipoprotein with the apical surface of LLC-PK1 renal tubular cells sustains the properties of orientated monolayers. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1996, Volume: 11, Issue:3 Topics: Albumins; Animals; Cell Membrane; Cell Membrane Permeability; Cells, Cultured; Hypolipidemic Agents; Inulin; Kidney Tubules, Proximal; Lipoproteins, HDL; LLC-PK1 Cells; Lovastatin; Mevalonic Acid; Monosaccharide Transport Proteins; Nephrotic Syndrome; Simvastatin; Swine	1996
Hyperlipidaemia, diet and simvastatin therapy in steroid-resistant nephrotic syndrome of childhood. Pediatric nephrology (Berlin, Germany), 1996, Volume: 10, Issue:2 Topics: Adolescent; Child; Child, Preschool; Cholesterol; Combined Modality Therapy; Creatinine; Diet; Drug Resistance; Enzyme Inhibitors; Feeding Behavior; Female; Glucocorticoids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Infant; Lovastatin; Male; Nephrotic Syndrome; Retrospective Studies; Serum Albumin; Simvastatin; Triglycerides	1996
[The effect of lovastatin on the development of adriamycin nephropathy in rats]. Sbornik lekarsky, 1995, Volume: 96, Issue:1 Topics: Animals; Antibiotics, Antineoplastic; Anticholesteremic Agents; Doxorubicin; Hyperlipidemias; Lipids; Lovastatin; Male; Nephrotic Syndrome; Rats; Rats, Wistar; Serum Albumin	1995
[Terminal myoglobinuric renal failure in lovastatin therapy with pre-existing chronic renal insufficiency]. Wiener klinische Wochenschrift, 1996, Volume: 108, Issue:11 Topics: Aged; Anticholesteremic Agents; Humans; Hypercholesterolemia; Kidney Failure, Chronic; Kidney Function Tests; Lovastatin; Male; Myoglobinuria; Nephrotic Syndrome; Renal Dialysis	1996
Severe nephrotic syndrome in a patient with Schönlein-Henoch purpura: complete remission after cyclosporin A. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1997, Volume: 12, Issue:4 Topics: Angiotensin-Converting Enzyme Inhibitors; Cyclosporine; Enalapril; Enzyme Inhibitors; Humans; Hydroxymethylglutaryl CoA Reductases; IgA Vasculitis; Immunosuppressive Agents; Lovastatin; Male; Methylprednisolone; Middle Aged; Nephrotic Syndrome; Plasmapheresis; Prednisone; Proteinuria	1997
Failure of antioxidant therapy to attenuate interstitial disease in rats with reversible nephrotic syndrome. Journal of the American Society of Nephrology : JASN, 1998, Volume: 9, Issue:2 Topics: Animals; Anticholesteremic Agents; Antioxidants; Cholesterol; Collagen; Female; Fibronectins; Fibrosis; Kidney; Lipid Peroxides; Lipoproteins, LDL; Liver; Lovastatin; Macrophages; Microscopy, Fluorescence; Nephrotic Syndrome; Organ Size; Probucol; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; Time Factors; Transforming Growth Factor beta; Treatment Failure; Vitamin E	1998
[Effects of pathogenetic therapy on blood cholesterol in patients with glomerulonephritis]. Terapevticheskii arkhiv, 2001, Volume: 73, Issue:6 Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; Anticholesteremic Agents; Antihypertensive Agents; Azathioprine; Captopril; Cholesterol; Creatinine; Cyclophosphamide; Data Interpretation, Statistical; Enalapril; Female; Glomerulonephritis; Humans; Immunosuppressive Agents; Lovastatin; Male; Nephrotic Syndrome; Prednisolone; Retrospective Studies; Tetrazoles; Time Factors; Valine; Valsartan	2001
Effect of simvastatin on plasma lipid and lipoprotein concentrations and low-density lipoprotein metabolism in the nephrotic syndrome. Clinical science (London, England : 1979), 1992, Volume: 82, Issue:6 Topics: Adult; Aged; Apolipoproteins B; Cholesterol; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Lipoproteins; Lipoproteins, LDL; Lovastatin; Male; Middle Aged; Nephrotic Syndrome; Simvastatin	1992
Lovastatin in the treatment of hypercholesterolemia in nephrotic syndrome due to diabetic nephropathy stage IV-V. Clinical nephrology, 1992, Volume: 37, Issue:6 Topics: Adult; Aged; Cholesterol; Creatinine; Diabetic Nephropathies; Female; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Nephrotic Syndrome; Triglycerides	1992
Treatment of nephrotic hyperlipidemia with lovastatin. Clinical nephrology, 1991, Volume: 36, Issue:1 Topics: Adult; Aged; Drug Evaluation; Female; Humans; Hyperlipidemias; Lovastatin; Male; Middle Aged; Nephrotic Syndrome; Time Factors	1991
Nephrotic syndrome and simvastatin. Lancet (London, England), 1990, Jun-02, Volume: 335, Issue:8701 Topics: Albuminuria; Anticholesteremic Agents; Follow-Up Studies; Humans; Lovastatin; Nephrotic Syndrome; Simvastatin	1990
Lovastatin and nephrotic syndrome. Southern medical journal, 1991, Volume: 84, Issue:4 Topics: Adult; Humans; Hypercholesterolemia; Lovastatin; Male; Nephrotic Syndrome; Recurrence; Remission Induction	1991
Toxicity of lovastatin in rats with experimentally induced nephrotic syndrome. Nephron, 1990, Volume: 56, Issue:4 Topics: Animals; Cholesterol; Hyperlipidemias; Lovastatin; Male; Nephrotic Syndrome; Rats; Rats, Inbred Strains; Triglycerides	1990
Lovastatin ameliorates the development of glomerulosclerosis and uremia in experimental nephrotic syndrome. American journal of kidney diseases : the official journal of the National Kidney Foundation, 1990, Volume: 15, Issue:1 Topics: Animals; Blood Urea Nitrogen; Cholesterol; Female; Glomerulonephritis; Glomerulosclerosis, Focal Segmental; Hypercholesterolemia; Kidney Glomerulus; Lovastatin; Nephrotic Syndrome; Rats; Rats, Inbred Strains; Uremia	1990
The effects of lovastatin in hyperlipidemic patients with the nephrotic syndrome. American journal of kidney diseases : the official journal of the National Kidney Foundation, 1990, Volume: 15, Issue:1 Topics: Adult; Aged; Apolipoproteins; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Creatinine; Female; Humans; Hyperlipidemias; Lovastatin; Male; Middle Aged; Nephrotic Syndrome	1990
Lipid-lowering drugs in treatment of hyperlipidaemia associated with nephrotic syndrome. Lancet (London, England), 1989, May-06, Volume: 1, Issue:8645 Topics: Animals; Drug Evaluation, Preclinical; Hyperlipidemias; Lovastatin; Male; Nephrotic Syndrome; Random Allocation; Rats	1989
Lovastatin therapy in nephrotic hyperlipidemia: effects on lipoprotein metabolism. Kidney international, 1988, Volume: 33, Issue:6 Topics: Aged; Apolipoproteins B; Cholesterol; Cholesterol, LDL; Cholesterol, VLDL; Humans; Hyperlipidemias; Lipoproteins, VLDL; Lovastatin; Middle Aged; Nephrotic Syndrome; Triglycerides	1988